Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia

Bedaquiline is currently a key drug for treating multidrug-resistant or rifampin-resistant tuberculosis. We report and discuss the unusual development of resistance to bedaquiline in a teenager in Namibia, despite an optimal background regimen and adherence. The report highlights the risk for bedaq...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Gunar Günther, Lusia Mhuulu, Azaria Diergaardt, Viola Dreyer, Maria Moses, Kaarna Anyolo, Nunurai Ruswa, Mareli Claassens, Stefan Niemann, Emmanuel Nepolo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Centers for Disease Control and Prevention 2024-03-01
Edice:	Emerging Infectious Diseases
Témata:	tuberculosis TB tuberculosis and other mycobacteria bacteria respiratory infections bedaquiline
On-line přístup:	https://wwwnc.cdc.gov/eid/article/30/3/24-0134_article
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!